Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

1.1K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
1.1K
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

354
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
354
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

419
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
419
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

327
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
327

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Enterovirus genus respiratory infections and co-infections: a cross-sectional study in a Northeast Italian Hospital (2023-2025).

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Pattern of lymph node spread in gastric cancer: Western multicenter retrospective study.

BJS open·2026
Same author

Zebrafish behavioral assessment as a first-tier whole-organism NAM for developmental neurotoxicity: A multi-laboratory evaluation.

Neurotoxicology·2026
Same author

Seasonality and environmental determinants of exhaled nitric oxide in individuals with and without chronic respiratory diseases.

Environmental epidemiology (Philadelphia, Pa.)·2026
Same author

From urge to action: an integrative neuropsychological model of tic generation in Tourette syndrome.

Frontiers in psychiatry·2026
Same author

Risk of obstructive sleep apnea among healthcare workers: a systematic review and meta-analysis.

Scientific reports·2026

Related Experiment Video

Updated: Aug 23, 2025

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

17.1K

Study protocol-Evoked craving in high-dose benzodiazepine users.

Lorenzo Zamboni1,2, Silvia Toldo3, Francesca Fusina4,5

  • 1Unit of Addiction Medicine, Department of Internal Medicine, Integrated University Hospital of Verona, Policlinico "G.B. Rossi", Verona, Italy.

Frontiers in Psychiatry
|October 31, 2022
PubMed
Summary
This summary is machine-generated.

Virtual reality effectively assesses benzodiazepine (BDZ) craving and cue reactivity in substance use disorder (SUD) patients. Exposure to BDZ-related virtual environments significantly increased craving compared to neutral scenarios.

Keywords:
abuseaddictionbenzodiazepinecue reactivityvirtual reality

More Related Videos

A General Method for Evaluating Incubation of Sucrose Craving in Rats
12:44

A General Method for Evaluating Incubation of Sucrose Craving in Rats

Published on: November 4, 2011

13.4K
Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm
08:29

Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm

Published on: June 7, 2018

11.7K

Related Experiment Videos

Last Updated: Aug 23, 2025

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

17.1K
A General Method for Evaluating Incubation of Sucrose Craving in Rats
12:44

A General Method for Evaluating Incubation of Sucrose Craving in Rats

Published on: November 4, 2011

13.4K
Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm
08:29

Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm

Published on: June 7, 2018

11.7K

Area of Science:

  • Neuroscience
  • Psychology
  • Addiction Medicine

Background:

  • Benzodiazepine (BDZ) abuse is a challenging substance use disorder (SUD).
  • Craving and cue reactivity (CR) are critical in maintaining BDZ addiction and relapse.
  • Limited research exists on CR and craving in BDZ abuse treatment.

Purpose of the Study:

  • To assess the feasibility of virtual reality (VR) for studying BDZ craving and CR.
  • To investigate the impact of substance-related environmental cues on BDZ craving and affective states.
  • To understand the influence of CR and craving on mood and attention in SUD treatment.

Main Methods:

  • Recruited healthy controls and BDZ-dependent patients undergoing detoxification.
  • Utilized three VR scenarios: neutral, BDZ-related (no cues), and BDZ-related (with cues).
  • Measured craving (VAS), mood (POMS), attention (AAS), VR sickness (SSQ), and presence (PQ).

Main Results:

  • Patients exhibited higher craving levels than controls.
  • Exposure to BDZ-related VR cues significantly increased craving compared to neutral scenarios.
  • VR demonstrated feasibility for assessing craving and CR in BDZ abuse.

Conclusions:

  • VR is a promising tool for assessing key phenomena in BDZ abuse.
  • Cue reactivity plays a significant role in driving craving in BDZ SUD.
  • Findings can inform the development of targeted interventions for BDZ addiction.